Company Valuation: Verastem, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 373.5 84.56 205.7 230.1 595.8 395.4 - -
Change - -77.36% 143.23% 11.87% 158.95% -33.64% - -
Enterprise Value (EV) 1 373.5 84.56 205.7 230.1 595.8 230.4 185.8 298.6
Change - -77.36% 143.23% 11.87% 158.95% -61.33% -19.36% 60.7%
P/E -5x -1.06x -2.06x -1.41x -2.56x -2.85x -4.03x -6.01x
PBR - - - - - - - -
PEG - 0.14x 0.2x 0.19x 0.1x 0.1x 0.1x 0.2x
Capitalization / Revenue 182x 32.6x - 23x 19.3x 3.87x 2.21x 1.5x
EV / Revenue 182x 32.6x - 23x 19.3x 2.25x 1.04x 1.13x
EV / EBITDA - - - - - - - -
EV / EBIT -6.08x -1.16x -2.23x -2x -3.5x -1.33x -1.32x -3.14x
EV / FCF - - -2.38x -2.2x -4.05x -1.41x -1.39x -3.64x
FCF Yield - - -42% -45.5% -24.7% -70.7% -72.1% -27.5%
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 -4.92 -4.56 -3.96 -3.66 -3.02 -1.579 -1.117 -0.7483
Distribution rate - - - - - - - -
Net sales 1 2.053 2.596 - 10 30.91 102.3 178.8 263.8
EBITDA - - - -114.9 - - - -
EBIT 1 -61.41 -72.94 -92.08 -115 -170.1 -173 -140.4 -95.04
Net income 1 -71.2 -73.81 -87.37 -130.6 -209.5 -166.2 -141.6 -99.51
Net Debt 1 - - - - - -165 -209.6 -96.8
Reference price 2 24.600 4.830 8.140 5.170 7.720 4.500 4.500 4.500
Nbr of stocks (in thousands) 15,182 17,508 25,268 44,507 77,182 87,874 - -
Announcement Date 3/28/22 3/14/23 3/14/24 3/20/25 3/4/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
-2.85x2.25x - - 395M
35.82x9.04x28.05x0.05% 59.1B
20.71x6.39x13.83x1.45% 55.19B
-19.36x4.94x-8.63x-.--% 24.67B
-42.26x14x-40.82x-.--% 24.19B
24.52x4.85x12.6x-.--% 19.69B
24.5x4.84x16.04x-.--% 17.56B
48.53x19.97x52.67x0.06% 16.22B
-520.97x35.77x-3987.51x-.--% 14.84B
17.56x5.1x11.91x-.--% 14.04B
Average -41.38x 10.72x -433.54x 0.17% 24.59B
Weighted average by Cap. -16.36x 9.98x -229.68x 0.34%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. VSTM Stock
  4. Valuation Verastem, Inc.